Role of HDL in cholesteryl ester metabolism of lipopolysaccharide-activated P388D1 macrophages

Journal of Lipid Research

Volumn 54, Issue 11, 2013, Pages 3158-3169

  Uda, Sabrina ^a   Spolitu, Stefano ^a   Angius, Fabrizio ^a   Collu, Maria ^a   Accossu, Simonetta ^a   Banni, Sebastiano ^a   Murru, Elisabetta ^a   Sanna, Francesca ^a   Batetta, Barbara ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Immune cells; Inflammation; Microbial stimulus

Indexed keywords

CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHYTOHEMAGGLUTININ; SCAVENGER RECEPTOR BI; TOLL LIKE RECEPTOR 4;

ACCURACY; ARTICLE; BIOSYNTHESIS; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESTERIFICATION; HUMAN; HUMAN CELL; LIPID ANALYSIS; LIPID METABOLISM; LIPOGENESIS; LYMPHOCYTE ACTIVATION; MACROPHAGE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

IMMUNE CELLS; INFLAMMATION; MICROBIAL STIMULUS;

ANIMALS; ANTIGENS, CD36; CELL LINE; CHOLESTEROL ESTERS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS, HDL; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MONOCYTES; NF-KAPPA B; OXIDATION-REDUCTION; PHYTOHEMAGGLUTININS; TOLL-LIKE RECEPTOR 4;

EID: 84886020160     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M042663     Document Type: Article

References (66)

1. Schmitz, G., and M. Grandl. 2008. Lipid homeostasis in macrophages - implications for atherosclerosis. Rev. Physiol. Biochem. Pharmacol. 160: 93-125.
2. Fazio, S., and M. F. Linton. 2010. High-density lipoprotein therapeutics and cardiovascular prevention. J. Clin. Lipidol. 4: 411-419.
3. Säemann, M. D., M. Poglitsch, C. Kopecky, M. Haidinger, W. H. Horl, and T. Weichhart. 2010. The versatility of HDL: a crucial antiinfl ammatory regulator. Eur. J. Clin. Invest. 40: 1131-1143.
4. Ghosh, S. 2011. Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization. Expert Rev. Cardiovasc. Ther. 9: 329-340.
5. Dessì, S., and B. Batetta. 2003. Cholesterol metabolism in human tumors. In Cell Growth and Cholesterol Esters. Landes Bioscience, editor. Kluwer Academic/Plenum Publishers, New York. 34-47.
6. Dessì, S., B. Batetta, D. Pulisci, O. Spano, C. Anchisi, L. Tessitore, P. Costelli, F. M. Baccino, E. Aroasio, and P. Pani. 1994. Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer. 73: 253-258. (Pubitemid 24030598)
7. Dessì, S., B. Batetta, O. Spano, F. Sanna, M. Tonello, M. Giacchino, L. Tessitore, P. Costelli, F. M. Baccino, E. Madon, et al. 1995. Clinical remission is associated with restoration of normal highdensity lipoprotein cholesterol levels in children with malignancies. Clin. Sci. (Lond.). 89: 505-510.
8. Ginsberg, H. N., N. A. Le, and H. S. Gilbert. 1986. Altered high density lipoprotein metabolism in patients with myeloproliferative disorders and hypocholesterolemia. Metabolism. 35: 878-882. (Pubitemid 16025554)
9. Tosi, M. R., and V. Tugnoli. 2005. Cholesteryl esters in malignancy. Clin. Chim. Acta. 359: 27-45. (Pubitemid 41121953)
10. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196. (Pubitemid 38802622)
11. Beisel, W. R. 1975. Metabolic response to infection. Annu. Rev. Med. 26: 9-20.
12. Straub, R. H., M. Cutolo, F. Buttgereit, and G. Pongratz. 2010. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. J. Intern. Med. 267: 543-560.
13. Bentz, M. H., and J. Magnette. 1998. Hypocholesterolemia during the acute phase of an inflammatory reaction of infectious origin. 120 cases. Rev. Med. Interne. 19: 168-172. (Pubitemid 28175355)
14. Feingold, K. R., I. Staprans, R. A. Memon, A. H. Moser, J. K. Shigenaga, W. Doerrler, C. A. Dinarello, and C. Grunfeld. 1992. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J. Lipid Res. 33: 1765-1776. (Pubitemid 23006653)
15. Memon, R. A., I. Staprans, M. Noor, W. M. Holleran, Y. Uchida, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2000. Infection and inflammation induce LDL oxidation in vivo. Arterioscler. Thromb. Vasc. Biol. 20: 1536-1542. (Pubitemid 30353885)
16. Haas, M. J., and A. D. Mooradian. 2010. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab. Res. Rev. 26: 90-99.
17. Pruzanski, W., E. Stefanski, F. C. de Beer, M. C. de Beer, A. Ravandi, and A. Kuksis. 2000. Comparative analysis of lipid composition of normal and acute-phase high density lipoproteins. J. Lipid Res. 41: 1035-1047. (Pubitemid 30483006)
18. Clifton, P. M., A. M. Mackinnon, and P. J. Barter. 1985. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J. Lipid Res. 26: 1389-1398. (Pubitemid 16189736)
19. McGillicuddy, F. C., M. de la Llera Moya, C. C. Hinkle, M. R. Joshi, E. H. Chiquoine, J. T. Billheimer, G. H. Rothblat, and M. P. Reilly. 2009. Inflammation impairs reverse cholesterol transport in vivo. Circulation. 119: 1135-1145.
20. Lehr, H. A., T. A. Sagban, C. Ihling, U. Zahringer, K. D. Hungerer, M. Blumrich, K. Reifenberg, and S. Bhakdi. 2001. Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 104: 914-920. (Pubitemid 32778043)
21. Rupprecht, H. J., S. Blankenberg, C. Bickel, G. Rippin, G. Hafner, W. Prellwitz, W. Schlumberger, and J. Meyer. 2001. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 104: 25-31. (Pubitemid 32623285)
22. Stoll, L. L., G. M. Denning, and N. L. Weintraub. 2004. Potential role of endotoxin as a proinflammatory mediator of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 2227-2236. (Pubitemid 39658022)
23. Beck, J., R. Garcia, G. Heiss, P. S. Vokonas, and S. Offenbacher. 1996. Periodontal disease and cardiovascular disease. J. Periodontol. 67: 1123-1137. (Pubitemid 126613093)
24. Söder, P. O., B. Söder, J. Nowak, and T. Jogestrand. 2005. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke. 36: 1195-1200. (Pubitemid 40798738)
25. Blankenberg, S., H. J. Rupprecht, C. Bickel, C. Espinola-Klein, G. Rippin, G. Hafner, M. Ossendorf, K. Steinhagen, and J. Meyer. 2001. Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease. Circulation. 103: 2915-2921. (Pubitemid 32578128)
26. Corrado, E., M. Rizzo, R. Tantillo, I. Muratori, F. Bonura, G. Vitale, and S. Novo. 2006. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke. 37: 482-486. (Pubitemid 43732010)
27. Imler, J. L., and L. Zheng. 2004. Biology of Toll receptors: lessons from insects and mammals. J. Leukoc. Biol. 75: 18-26. (Pubitemid 38166775)
28. Matsumoto, A., M. Naito, H. Itakura, S. Ikemoto, H. Asaoka, I. Hayakawa, H. Kanamori, H. Aburatani, F. Takaku, H. Suzuki, et al. 1990. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87: 9133-9137. (Pubitemid 120030579)
29. Murphy, J. E., P. R. Tedbury, S. Homer-Vanniasinkam, J. H. Walker, and S. Ponnambalam. 2005. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis. 182: 1-15. (Pubitemid 41188365)
30. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
31. Fielding, C. J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
32. Li, L., and H. J. Pownall. 2001. Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages. Biochim. Biophys. Acta. 1530: 111-122. (Pubitemid 32121886)
33. Millican, S. A., M. Bagga, R. Eddy, M. J. Mitchinson, and J. V. Hunt. 1997. Effect of glucose-mediated LDL oxidation on the P388D1 macrophage-like cell line. Atherosclerosis. 129: 17-25. (Pubitemid 27104245)
34. Glaser, K. B., R. Asmis, and E. A. Dennis. 1990. Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J. Biol. Chem. 265: 8658-8664.
35. Li, J., L. Ye, D. R. Cook, X. Wang, J. Liu, D. L. Kolson, Y. Persidsky, and W. Z. Ho. 2011. Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages. J. Neuroinflammation. 8: 15.
36. Conti, M., F. Sanna, G. A. Farci, S. Uda, G. Porcu, M. Collu, R. R. Bonatesta, and B. Batetta. 2010. Abnormal macrophage response to microbial stimulus in a 43-year-old man with a severe form of atherosclerosis: a case report. J. Med. Case Rep. 4: 183.
37. Caroleo, M. C., N. Costa, L. Bracci-Laudiero, and L. Aloe. 2001. Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. J. Neuroimmunol. 113: 193-201. (Pubitemid 32112745)
38. Fulghesu, A. M., F. Sanna, S. Uda, R. Magnini, E. Portoghese, and B. Batetta. 2011. IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. Mediators Inflamm. 2011: 389317.
39. Schildberger, A., E. Rossmanith, T. Eichhorn, K. Strassl, and V. Weber. 2013. Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm. 2013: 697972.
40. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
41. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
42. Angioni, E., G. Lercker, N. G. Frega, G. Carta, M. P. Melis, E. Murru, S. Spada, and S. Banni. 2002. UV spectral properties of lipids as a tool for their identification. Eur. J. Lipid Sci. Technol. 104: 59-64. (Pubitemid 34848666)
43. Banni, S., G. Carta, M. S. Contini, E. Angioni, M. Deiana, M. A. Dessì, M. P. Melis, and F. P. Corongiu. 1996. Characterization of conjugated diene fatty acids in milk, dairy products, and lamb tissues . J. Nutr. Biochem. 7: 150-155. (Pubitemid 26128276)
44. Cullen, P., M. Fobker, K. Tegelkamp, K. Meyer, F. Kannenberg, A. Cignarella, A. Benninghoven, and G. Assmann. 1997. An improved method for quantification of cholesterol and cholesteryl esters in human monocyte-derived macrophages by high performance liquid chromatography with identification of unassigned cholesteryl ester species by means of secondary ion mass spectrometry. J. Lipid Res. 38: 401-409. (Pubitemid 27118051)
45. Banni, S., E. Angioni, M. S. Contini, G. Carta, V. Casu, G. A. Iengo, M. P. Melis, M. Deiana, M. A. Dessì, and F. P. Corongiu. 1998. Conjugated linoleic acid and oxidative stress. J. Am. Oil Chem. Soc. 75: 261-267. (Pubitemid 128607986)
46. Diaz, G., B. Batetta, F. Sanna, S. Uda, C. Reali, F. Angius, M. Melis, and A. M. Falchi. 2008. Lipid droplet changes in proliferating and quiescent 3T3 fibroblasts. Histochem. Cell Biol. 129: 611-621.
47. Greenspan, P., and S. D. Fowler. 1985. Spectrofluorometric studies of the lipid probe, nile red. J. Lipid Res. 26: 781-789. (Pubitemid 15046441)
48. Stephan, Z. F., and E. C. Yurachek. 1993. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J. Lipid Res. 34: 325-330. (Pubitemid 23067537)
49. Pagler, T. A., S. Golsabahi, M. Doringer, S. Rhode, G. J. Schutz, M. Pavelka, C. Wadsack, M. Gauster, A. Lohninger, H. Laggner, et al. 2006. A Chinese hamster ovarian cell line imports cholesterol by high density lipoprotein degradation. J. Biol. Chem. 281: 38159-38171. (Pubitemid 46041939)
50. Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85. (Pubitemid 16258399)
51. Uda, S., S. Accossu, S. Spolitu, M. Collu, F. Angius, F. Sanna, S. Banni, C. Vacca, E. Murru, C. Mulas, et al. 2012. A lipoprotein source of cholesteryl esters is essential for proliferation of CEMCCRF lymphoblastic cell line. Tumour Biol. 33: 443-453.
52. Sanna, F., R. R. Bonatesta, B. Frongia, S. Uda, S. Banni, M. P. Melis, M. Collu, C. Madeddu, R. Serpe, S. Puddu, et al. 2007. Production of inflammatory molecules in peripheral blood mononuclear cells from severely glucose-6-phosphate dehydrogenase-deficient subjects. J. Vasc. Res. 44: 253-263. (Pubitemid 46956828)
53. Li, Y., R. F. Schwabe, T. DeVries-Seimon, P. M. Yao, M. C. Gerbod-Giannone, A. R. Tall, R. J. Davis, R. Flavell, D. A. Brenner, and I. Tabas. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280: 21763-21772. (Pubitemid 40827824)
54. Duong, M., J. M. Petit, B. Martha, F. Galland, L. Piroth, A. Walldner, M. Grappin, M. Buisson, L. Duvillard, P. Chavanet, et al. 2006. Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy. HIV Clin. Trials. 7: 41-47. (Pubitemid 44082686)
55. Liuba, P., J. Persson, J. Luoma, S. Yla-Herttuala, and E. Pesonen. 2003. Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media. Eur. Heart J. 24: 515-521. (Pubitemid 36343097)
56. Nakamura, T., N. Shibata, T. Nishimoto-Shibata, D. Feng, M. Ikemoto, K. Motojima, O. N. Iso, K. Tsukamoto, M. Tsujimoto, and H. Arai. 2005. Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1. Proc. Natl. Acad. Sci. USA. 102: 13404-13409. (Pubitemid 41420860)
57. Murao, K., H. Imachi, W. Cao, X. Yu, J. Li, K. Yoshida, R. A. Ahmed, K. Matsumoto, T. Nishiuchi, N. C. Wong, et al. 2006. High-density lipoprotein is a potential growth factor for adrenocortical cells. Biochem. Biophys. Res. Commun. 344: 226-232.
58. Pussinen, P. J., B. Karten, A. Wintersperger, H. Reicher, M. McLean, E. Malle, and W. Sattler. 2000. The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake. Biochem. J. 349: 559-566. (Pubitemid 30465791)
59. Wadsack, C., B. Hirschmugl, A. Hammer, S. Levak-Frank, K. F. Kozarsky, W. Sattler, and E. Malle. 2003. Scavenger receptor class B, type I on non-malignant and malignant human epithelial cells mediates cholesteryl ester-uptake from high density lipoproteins. Int. J. Biochem. Cell Biol. 35: 441-454. (Pubitemid 36140066)
60. Smith, J. D. 2010. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein. J. Clin. Lipidol. 4: 382-388.
61. Tabas, I. 2002. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110: 905-911.
62. Meuwese, M. C., E. de Groot, R. Duivenvoorden, M. D. Trip, L. Ose, F. J. Maritz, D. C. Basart, J. J. Kastelein, R. Habib, M. H. Davidson, et al. 2009. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial. JAMA. 301: 1131-1139.
63. Abeywardena, M. Y., W. R. Leifert, K. E. Warnes, J. N. Varghese, and R. J. Head. 2009. Cardiovascular biology of interleukin-6. Curr. Pharm. Des. 15: 1809-1821.
64. Brasier, A. R. 2010. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc. Res. 86: 211-218.
65. Casas, J. P., T. Shah, A. D. Hingorani, J. Danesh, and M. B. Pepys. 2008. C-reactive protein and coronary heart disease: a critical review. J. Intern. Med. 264: 295-314.
66. Andrés, V., O. M. Pello, and C. Silvestre-Roig. 2012. Macrophage proliferation and apoptosis in atherosclerosis. Curr. Opin. Lipidol. 23: 429-438.